Föreläsningar och seminarier StratRegen Seminar Series med Yuval Rinkevich
Välkommen till ett nytt StratRegen seminarium, TORSDAG, den 28:e maj 2026 kl. 12.30-13.30, Salen Eva & Georg Klein, Biomedicum, Campus Solna med direktsändning till DNA 5105, Neo, entréplan, Flemingsberg.

Title: Emerging perspectives in wound healing
Speaker: Professor Yuval Rinkevich, Chinese Institutes For Medical Research, Beijing (CIMR)
Publikationer
Distinct fibroblast assemblies establish scarless regeneration.
Ye H, Yu Q, Lee AJKS, Dong W, Chang Z, Correa-Gallegos D, Jiang D, Dai R, Schorpp K, Hadian K, Machens HG, Rinkevich Y
Cell Rep 2026 Jan;45(1):116767
A mesothelial differentiation gateway drives fibrosis.
Kadri S, Fischer A, Mück-Häusl M, Han W, Kadri A, Lin Y, Yang L, Hu S, Ye H, Ramesh P, Ansari M, Schiller HB, Machens HG, Rinkevich Y
Nat Commun 2025 Sep;16(1):8295
Targeting pleuro-alveolar junctions reverses lung fibrosis in mice.
Fischer A, Han W, Hu S, Mück-Häusl M, Wannemacher J, Kadri S, Lin Y, Dai R, Christ S, Su Y, Dasgupta B, Sardogan A, Deisenhofer C, Dutta S, Kadri A, Güney TG, Correa-Gallegos D, Mayr CH, Hatz R, Stoleriu MG, Lindner M, Hilgendorff A, Adler H, Machens HG, Schiller HB, Hauck SM, Rinkevich Y
Nat Commun 2025 Jan;16(1):173
CD201+ fascia progenitors choreograph injury repair.
Correa-Gallegos D, Ye H, Dasgupta B, Sardogan A, Kadri S, Kandi R, Dai R, Lin Y, Kopplin R, Shenai DS, Wannemacher J, Ichijo R, Jiang D, Strunz M, Ansari M, Angelidis I, Schiller HB, Volz T, Machens HG, Rinkevich Y
Nature 2023 Nov;623(7988):792-802
Wound infiltrating adipocytes are not myofibroblasts.
Kalgudde Gopal S, Dai R, Stefanska AM, Ansari M, Zhao J, Ramesh P, Bagnoli JW, Correa-Gallegos D, Lin Y, Christ S, Angelidis I, Lupperger V, Marr C, Davies LC, Enard W, Machens HG, Schiller HB, Jiang D, Rinkevich Y
Nat Commun 2023 May;14(1):3020
Sandwiches and coffee will be provided.

Host
Enric Llorens Bobadilla
Biträdande LektorElif Eroglu
Senior ForskareStratRegen supports researchers, research programs and infrastructure at the Karolinska Institutet (KI) within the field of stem cells and regenerative medicine based on scope, quality, and the potential to strengthen and develop the field.
